Iowa Medical Cannabis Products & Rules

Last verified: April 2026

Allowed and Prohibited Forms

Per Iowa Code §124E.4 and 641 IAC 154.14:

The smokable-flower prohibition is among the strictest in the nation — most medical states allow it. Senate Study Bill 1113 (2025) and HF 950 / SF 163 (2025) sought to permit vaporizable dried raw cannabis; HF 950 cleared committee but did not reach a floor vote. The form-restriction regime reflects the Medical Cannabidiol Board’s clinical preference for pharmaceutical-style delivery and persistent opposition to combustion.

The 2024 Gummy Approval

Iowa expanded its allowed-form list in 2024 to include limited gummy products under the “lozenge / gum” pathway. Gummy products from Iowa manufacturers are formulated as dosage-form medicine rather than confectionery and remain subject to child-resistant packaging and pharmacist-consultation requirements.

THC Concentration Per Product

Following HF 2589 (2020), there is no per-product THC concentration cap. A 1-gram vape cartridge may contain 800 mg or more of THC. Sublingual tinctures are commonly formulated at 30 mg/mL with 30 mL bottles (900 mg per bottle). Capsules range from 5 mg to 25 mg of THC each. The cap that matters is the patient-side 4.5-g per 90-day total at the cash register, not the product-side concentration.

Packaging, Labeling, and Tracking

• Child-resistant packaging required on all products.
• Opaque containers mandatory.
• Lot tracking via the Iowa Bureau of Cannabis Regulation electronic verification system (BioTrackTHC). Every product carries a lot number tied to the manufacturer and testing batch.
• Pharmacist consultation at every point of sale, required by HF 2589 and 641 IAC 154.46.
• Patient ID scan against the 90-day THC ledger before any sale.

Iowa Code §124E.7 and 641 IAC 154 require manufacturer-level lab testing for THC, CBD, minor cannabinoids, pesticides, heavy metals, microbial contamination, residual solvents, and dosing consistency. Heavy-metal testing for vape cartridges was added in 2023.

Iowa Code §124E.7; 641 IAC 154

Lab Testing

Iowa Code §124E.7 and 641 IAC 154 require manufacturers to contract with an independent laboratory for routine testing of:

• THC, CBD, and minor cannabinoid content;
• Pesticide and heavy-metal contamination (heavy-metal testing for vape cartridges added in 2023);
• Microbial contamination (mold, yeast, E. coli, salmonella);
• Residual solvents in extracts;
• Consistency of dosing across batches.

Until 2024, lab testing was conducted exclusively at the University of Iowa State Hygienic Laboratory (SHL). The Bureau of Cannabis Regulation has been working through 2024–2025 to authorize independent testing labs as a regulatory priority.

Pricing

Typical 2025–2026 Iowa medical cannabis pricing:

Effective price per gram of THC equivalent: $65–$120. By comparison, Illinois recreational vape cartridges typically run $40–$70 per gram (post-tax). Missouri recreational is even cheaper. The Iowa price premium reflects the two-manufacturer / five-dispensary supply restriction.

Rules of Use

• Public consumption is prohibited under Iowa Code §124E.12.
• CDL drivers may not hold Iowa medical cannabidiol cards consistent with their license; federal DOT regulations under 49 CFR Part 40 disqualify any THC use.
• No on-site consumption at dispensaries (§124E.9).
• Possession in a vehicle remains subject to Iowa OWI rules under §321J.2 — THC metabolites are zero-tolerance per se. See OWI & driving.
• No interstate transport of any Iowa-purchased product across state lines, even into other legal states. Federal Controlled Substances Act, 21 U.S.C. §841.

Recall History

Iowa’s manufacturer-level testing regime has produced relatively few public recalls; when issues are identified, the Bureau of Cannabis Regulation works directly with manufacturers and dispensaries on lot-specific holds. Patients can verify lot status through their dispensary.

Explore More